Sucralfate
NDC 82182-106, Sucralfate, suspension, from Pacific Pharma, Inc..
- Product NDC
- 82182-106
- Status
- Listed
- Labeler
- Pacific Pharma, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA019183
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82182-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUCRALFATE1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC]; Organometallic Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82182-106-14 | 82182010614 | 420 mL in 1 BOTTLE (82182-106-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7407c58e-766f-4e93-a1bb-c77892ae0174NADAC price for package 82182010614
GET /v1/drugs/nadac/82182010614
Use it
Look up 82182-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82182-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82182-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.